Syneos Health Releases 2022 Dealmakers’ Intentions Survey

Syneos Health Releases 2022 Dealmakers’ Intentions Survey
As Industry Dynamics Shift, Smaller Biotechnology Companies Will Continue to Drive Dealmaking in 2022
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’ Intentions Survey.

Read the source article at Health Technology Net –
2022-01-11 16:05:00